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eceptor protein tyrosine phosphatases (RPTPs) are
implicated as regulators of axon growth and guid-
ance. Genetic deletions in the ﬂy have shown that
type III RPTPs are important in axon pathﬁnding, but noth-
ing is known about their function on a cellular level. Pre-
vious experiments in our lab have identiﬁed a type III
RPTP, CRYP-2/cPTPRO, speciﬁcally expressed during the
period of axon outgrowth in the chick brain; cPTPRO is
expressed in the axons and growth cones of retinal and
tectal projection neurons. We constructed a fusion protein
containing the extracellular domain of cPTPRO fused to
the Fc portion of mouse immunoglobulin G-1, and used it
R
 
to perform in vitro functional assays. We found that the
extracellular domain of cPTPRO is an antiadhesive, neu-
rite inhibitory molecule for retinal neurons. In addition,
cPTPRO had potent growth cone collapsing activity in
vitro, and locally applied gradients of cPTPRO repelled
growing retinal axons. This chemorepulsive effect could
be regulated by the level of cGMP in the growth cone. Im-
munohistochemical examination of the retina indicated
 
that cPTPRO has at least one heterophilic binding part-
ner in the retina. Taken together, our results indicate that
cPTPRO may act as a guidance cue for retinal ganglion
cells during vertebrate development.
 
Introduction
 
Axons are guided to their targets by a complex complement
of extracellular navigational cues. These cues may be dif-
fusible or substrate-bound molecules, but each interacts
with specific neuronal receptors, initiating signaling cascades
within the neuron that ultimately regulate the assembly of
cytoskeletal elements and the addition of axonal membrane.
The regulatory ligands influencing axon growth and guid-
ance are a diverse lot, including cell adhesion molecules
(CAMs),* netrins, semaphorins, slits, and ephrins (Good-
man, 1996; Tessier-Lavigne and Goodman, 1996; Drescher
et al., 1997; Harris and Holt, 1999). These proteins are
linked together in that their signaling depends on tyrosine
phosphorylation: either their receptors are tyrosine kinases
or they regulate signaling pathways that are dependent on
tyrosine kinases (Walsh and Doherty, 1996; Ming et al.,
1999; Tamagnone et al., 1999). Thus, the enzymes control-
ling tyrosine phosphorylation are critically important in
axon growth and guidance. In particular, the key roles
played by receptor protein tyrosine phosphatases (RPTPs) in
axon growth and guidance are increasingly appreciated (for
review see Bixby, 2000). The most compelling evidence for
such roles comes from genetic studies in 
 
Drosophila
 
, in
which loss-of-function mutations in CAM-like type IIa
(Dlar, PTP69D) and type III (PTP99A, PTP10D) RPTPs
cause severe neuronal pathfinding defects (Desai et al.,
1996; Krueger et al., 1996; Sun et al., 2000a, 2001).
 
In vertebrates, there is substantial evidence that type
II RPTPs influence axon growth and guidance. PTP-
 
 
 
(CRYP-
 
 
 
 in the chick), a type IIa RPTP, promotes retinal
ganglion cell (RGC) outgrowth on basement membranes
(Ledig et al., 1999a). PTP-
 
 
 
 is a homophilic CAM that pro-
motes outgrowth of forebrain neurons (Wang and Bixby,
1999) and is an attractive guidance cue in vitro (Sun et al.,
2000b). PTP-
 
 
 
 and leukocyte antigen-related protein (LAR)
knockout mice have specific neurological defects, some of
which relate to axon growth (Yeo et al., 1997; Elchebly et
al., 1999; Wallace et al., 1999). As for the type IIb RPTPs,
both PTP-
 
 
 
 and PTP-
 
 
 
 promote neurite outgrowth from
cultured primary neurons (Burden-Gulley and Brady-Kal-
 
Address correspondence to John Bixby, Dept. of Molecular and Cellular
Pharmacology and Neuroscience Program, University of Miami School of
Medicine, 1600 NW 10 Ave., R-189, Miami, FL 33136. Tel.: (305) 243-
4875. Fax: (305) 243-2970. E-mail: jbixby@miami.edu
L. Stepanek, Q.L. Sun, and J. Wang contributed equally to this work.
J. Wang’s present address is Dept. of Psychiatry, Wayne State University
School of Medicine, 540 E. Canfield Ave., 2309 Scott Hall, Detroit, MI
48201.
*Abbreviations used in this paper: CAM, cell adhesion molecule; ECD,
 
extracellular domain; LN, laminin; PDL, poly-
 
D
 
-lysine;
 
 
 
PTP, protein ty-
rosine phosphatase;
 
 
 
RGC, retinal ganglion cell;
 
 
 
RPTP, receptor PTP.
Key words: tyrosine phosphorylation; axon growth; chemorepulsion;
growth cone; chick embryo  
868 The Journal of Cell Biology 
 
|
 
 
 
Volume 154, 2001
 
nay, 1999; Drosopoulos et al., 1999). In contrast, essentially
nothing is known about the function of type III RPTPs
in the vertebrate nervous system. As mentioned above, ex-
periments in 
 
Drosophila
 
 suggest that the type III RPTPs
PTP99A and PTP10D are involved in axon pathfinding. Al-
though null mutants of these RPTPs have no discernible
phenotype, mutations in either of these molecules signifi-
cantly alter the neural phenotypes of type IIa mutants (Desai
et al., 1997; Sun et al., 2000a). However, these studies have
not provided information on the mechanisms underlying
RPTP function.
In a PCR-based screen of the chick brain, our lab identi-
fied a novel type III RPTP that we named CRYP-2 (Bodden
and Bixby, 1996).
 
 
 
Primary amino acid sequence analysis in-
dicates that CRYP-2 is a transmembrane molecule with
eight extracellular fibronectin type III repeats and one cyto-
plasmic phosphatase domain. Outside of the nervous sys-
tem, expression is seen only in the kidney (Chilton and
Stoker, 2000). Homologues of CRYP-2 have been found in
rabbits (GLEPP-1; Thomas et al., 1994), rats (RPTP-BK;
Tagawa et al., 1997), mice (mGLEPP/mPTPRO; Tome-
mori et al., 2000; Wang et al., 2000), and humans (Seimiya
et al., 1995; Wiggins et al., 1995). We believe that these
proteins all represent orthologues (unpublished data), and
we will henceforth use cPTPRO to denote the chick iso-
form.
PTPRO is expressed at the right time and in the right
place to be important in axon growth and guidance. PTPR
 
O
 
mRNA is selectively expressed in neurons in the brain dur-
ing the time of axon outgrowth in the chick embryo (Bod-
den and Bixby, 1996). In the retina, cPTPRO is selectively
expressed in the projection neurons (RGCs) and is concen-
trated in axons and growth cones. PTPRO is also expressed
in the optic tectum, the major target of the retinal projection
(Ledig et al., 1999b). This pattern of expression, together
with the genetic evidence involving cPTPR
 
O
 
’s closest rela-
tive in the fly, PTP10D, suggests that cPTPR
 
O
 
 plays a role
in axon growth and guidance. In this study, we used a vari-
ety of in vitro assays to investigate the potential functions of
cPTPR
 
O
 
. Our results indicate that in contrast to most other
RPTPs examined, the cPTPR
 
O
 
 extracellular domain (ECD)
is antiadhesive and neurite inhibitory, and acts as a repulsive
guidance cue for retinal neurons.
 
Results
 
cPTPRO protein is developmentally regulated in 
embryonic chick brain
 
cPTPRO mRNA is upregulated between embryonic days 8
(E8) and 13 (E13) in chick brain, coinciding with the major
period of axon outgrowth (Bodden and Bixby, 1996). To
determine if cPTPRO protein expression follows this pat-
tern, we used an antibody to a fusion protein from the ECD
of cPTPRO (Ledig et al., 1999b) to probe Western blots of
membrane fractions from chick brain. This antibody recog-
nized a specific cPTPRO band at 180 kD that was not
present in membranes from liver or muscle (unpublished
data). This size is similar to that seen for cPTPRO ortho-
logues in other species (Tagawa et al., 1994; Thomas et al.,
1994; Wiggins et al., 1995), and is the size encoded by the
full-length cDNA when expressed in transfected COS cells
(unpublished data). As the predicted protein encoded by the
PTPRO cDNA is 141 kD (Bodden and Bixby, 1996), our
data are consistent with a high degree of glycosylation.
PTPRO expression in brain was low at E5, increased dra-
matically between E7 and E10, then declined after E14,
consistent with our previous findings for mRNA expression
(Fig. 1). This pattern is similar to that suggested by immu-
nofluorescence experiments in retina and tectum, and is con-
sistent with our hypothesis that cPTPRO plays a role in
axon outgrowth during development.
In an earlier study, we reported a band at 330 kD that was
specifically recognized by an antibody to a cPTPRO peptide
sequence (Bodden and Bixby, 1996). This band was some-
times faintly visible in Western blots with the fusion protein
antibody (unpublished data). The relationship between this
band and the 180-kD band is not known.
 
Localization of cPTPRO binding sites in the retina
 
Although nothing is known concerning ligand–receptor
interactions of type III RPTPs, several type II RPTPs can
bind homophilically, serving as both ligands and receptors
(Bixby, 2000). Ligand–receptor interactions of these CAM-
like RPTPs as well as those of other CAMs have been exam-
ined productively using Fc fusion proteins of the ECDs
(Walsh and Doherty, 1997; Drosopoulos et al., 1999; Wang
and Bixby, 1999). To investigate these interactions for
cPTPRO, we fused the cDNA encoding the ECD of
Figure 1. cPTPRO protein is developmentally regulated in embry-
onic chick brain. 20  g of brain P2 fractions from E5, E7, E10, E14, 
E18, and E21 was separated by SDS-PAGE and subjected to Western 
blot analysis using affinity-purified anti-cPTPRO antibody. (A) 
cPTPRO migrated with an apparent molecular mass of 180 kD 
(arrow). Note the increase in expression from E5 to E10 and the 
decrease after E14. (B) Quantitative analysis from three independent 
experiments. Data were plotted as a percentage of the levels at
E10   SEM. 
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cPTPRO to the cDNA encoding the Fc domain of mouse
IgG-1 (mIgG; Fig. 2, A and B). This construct was used to
express the fusion protein (cPTPRO–Fc) in stably trans-
fected CHO cells, and purified with anti-mIgG agarose. As
expected, the purified protein migrated as a 170-kD band
under reducing conditions and as a 350-kD dimer under
nonreducing conditions (Fig. 2 C). Bands of these same sizes
were identified by an anti-cPTPRO antibody on Western
blots of the purified proteins (Fig. 2 D), confirming the
presence of the cPTPRO ECD in the fusion protein.
Previous experiments demonstrated that cPTPRO is
expressed in the embryonic chick retina. In particular,
cPTPRO is strongly expressed in RGCs and their axons
from E6 to E10 (when axons are growing to the tectum), in
various fiber layers of the retina by E10, and becomes down-
regulated after this time (Ledig et al., 1999b). We used the
cPTPRO–Fc fusion protein to localize potential binding
partners for cPTPRO in the retina. Sections of E7 chick ret-
ina were stained by binding cPTPRO–Fc to the sections,
followed by anti-Fc immunohistochemistry to localize the
bound fusion protein. cPTPRO binding sites were found in
most of the neural retina (except the photoreceptor layer),
with the strongest staining in the RGC layer and the weakest
in the outer plexiform layer (Fig. 3 B). The optic fiber layer,
containing the axons of the RGCs, was nearly devoid of
staining. Adjacent sections stained with antibodies to
cPTPRO confirmed that the majority of cPTPRO immu-
noreactivity is found both in the optic fiber layer and the
ganglion cell layer at this time (Fig. 3 D). Control sections
stained with mIgG alone demonstrated the specificity of
binding (Fig. 3, A and C). These results demonstrate the
presence of at least one cPTPRO binding partner in the ret-
ina, which apparently is expressed in several cell types. Be-
cause the distribution of cPTPRO and its binding partner
overlap but are not identical, our results suggest, but do not
prove, that cPTPRO has at least one heterophilic binding
partner in the retina during embryogenesis.
 
cPTPRO is antiadhesive for retinal neurons
 
The ECD of cPTPRO consists entirely of fibronectin type III
repeats (Bodden and Bixby, 1996). Because these motifs are
commonly found in the ECDs of CAMs (Baldwin et al.,
1996), and in some cases appear to mediate cell adhesion (Frei
et al., 1992; Appel et al., 1993), we predicted that the ECD of
Figure 2. Expression and purification of the
cPTPRO–Fc fusion protein. (A) Schematic diagram of 
cPTPRO. The horizontal line represents the plasma 
membrane (TM), with extracellular area above. The 
ECD of cPTPRO consists of eight fibronectin type III 
repeats ( ). The intracellular portion contains one 
phosphatase domain ( ). (B) Diagram of the fusion 
protein. The protein is a disulfide-linked (S-S) dimer, 
with the ECD of cPTPRO fused to the hinge and con-
stant regions (CH2, CH3) of mouse IgG-1. (C) 1  g
of purified cPTPRO–Fc was run on SDS-PAGE
and stained with Coomassie blue. (D) 20  g of
cPTPRO–Fc was subjected to Western blot analysis 
with an anti-cPTPRO antibody. cPTPRO–Fc migrated 
with an apparent molecular mass of 170 kD under re-
ducing (R) conditions and 350 kD under nonreducing 
(NR) conditions. Numbered arrows represent the mo-
lecular mass in kD of molecular weight standards. 
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cPTPRO could be an adhesive substrate for neurons. To test
this idea, we performed several types of cell adhesion assays.
Initial adhesion experiments employed retinal neurons, as
these appear to express a binding partner for the cPTPRO
ECD. Surprisingly, few retinal neurons adhered to spots con-
taining cPTPRO–Fc as a substrate, even though controls
demonstrated that the neurons adhered to spots of known ad-
hesive molecules (poly-
 
D
 
-lysine [PDL]) on the same dish.
Similar results were obtained with forebrain, cerebellar, and
ciliary ganglion neurons (unpublished data). These results
suggest that the cPTPRO ECD does not support neuronal
adhesion. However, because our ligand binding experiments
suggest an interaction of the cPTPRO ECD with retinal neu-
rons, we examined the possibility that cPTPRO–Fc could be
an antiadhesive substrate. In these experiments, cPTPRO or
mIgG as a control was spotted onto nitrocellulose substrates,
and a larger spot of laminin (LN) was then placed over the
first spot. This created a central spot of cPTPRO–Fc (or
mIgG) mixed with LN, surrounded by a ring of LN alone. In
our short-term assay, the center area containing LN plus
cPTPRO–Fc did not support neuronal adhesion, though reti-
nal neurons adhered well to the LN surround, or to the LN–
mIgG mixture (Fig. 4 A). Indeed, neurons failed to adhere to
or spread on the cPTPRO–LN mixture even after 24 h of cul-
ture (unpublished data). These results suggest that the cPTPRO
ECD is antiadhesive for retinal neurons.
In the experiments described above, it is possible that
cPTPRO–Fc somehow prevented LN from binding to the
substrate, rather than inhibiting adhesion. This seems un-
likely, as LN binds strongly to nitrocellulose and higher con-
centrations of mIgG did not affect adhesion to LN. How-
ever, to test this idea we did experiments in which cPTPRO
and LN were added simultaneously. We combined an opti-
mal concentration of LN (20 
 
 
 
g/ml) with varying concen-
trations of cPTPRO, and spotted the mixtures onto nitro-
cellulose-coated dishes. In these assays, concentrations of
cPTPRO between 25 and 100 
 
 
 
g/ml inhibit neuronal adhe-
sion to LN in a dose-dependent manner, whereas mIgG had
no effect on adhesion at 100 
 
 
 
g/ml (Fig. 4 B). Thus, the in-
hibitory effect of cPTPRO–Fc is due to the cPTPRO ECD
rather than the Fc fragment.
We also performed adhesion inhibition assays in which
N-cadherin was used as the adhesive substrate. Similar to the
situation for LN, cPTPRO–Fc inhibited retinal neuron adhe-
sion to N-cadherin in a dose-dependent manner when the
two were mixed before substrate coating (Fig. 4 C). Thus, the
cPTPRO ECD prevents retinal neurons from adhering to
substrates that are normally very adhesive. Because cPTPRO
inhibits adhesion when spotted simultaneously with adhesive
proteins, and because it inhibits adhesion mediated by two
unrelated proteins, it is unlikely that inhibition is simply due
to competition for binding sites on the substrate or on the ad-
hering neurons, though this remains a possibility.
 
cPTPRO ECD inhibits retinal neurite outgrowth
 
Although nothing is known concerning the activities of
type III RPTPs, the ECDs of several type II RPTPs have
been shown to promote neurite growth in vitro
 
 
 
(Burden-
Gulley and Brady-Kalnay, 1999; Drosopoulos et al., 1999;
Ledig et al., 1999a; Wang and Bixby, 1999). Furthermore,
cPTPRO is localized on RGC axons and growth cones,
putting it in the right location to influence axon growth
(Ledig et al., 1999b). To test whether the ECD of cPTPRO
can regulate neurite growth from retinal neurons, we
compared the growth of retinal neurites on substrates of
LN with growth on LN mixed with cPTPRO–Fc. As
cPTPRO is antiadhesive, we first coated substrates with
PDL to allow LN-independent adhesion of retinal neurons.
Retinal neurons adhered well, but did not grow neurites
when cultured overnight on PDL alone (Fig. 5 A). Neurons
adhered and grew numerous processes on an LN–PDL
substrate (Fig. 5 B). The presence of PDL allowed
strong neuronal adhesion when cultures were grown on a
cPTPRO–Fc substrate, but neurons mainly failed to ex-
tend neurites, showing that cPTPRO does not promote
retinal neurite growth (unpublished data). More interest-
ingly, LN-induced neurite formation was substantially in-
hibited by the presence of cPTPRO (Fig. 5, C and D).
Quantification of neurite outgrowth confirmed that the
presence of cPTPRO inhibited, in a dose-dependent man-
ner, both the percentage of cells with neurites and the aver-
age length of individual neurites (see Fig. 7, A and B). In
control experiments, mixing LN with IgG did not affect ei-
ther parameter of neurite growth, even when the IgG was
present at higher concentrations than the cPTPRO–Fc (see
Fig. 7). To ensure that the inhibitory effect of cPTPRO
was not due to competition for binding to the culture sub-
strate, we performed experiments in which LN was spotted
Figure 3.  Localization of cPTPRO binding sites and cPTPRO in E7 
chick retina. 10- m sections of chick retina were cut on a cryostat. 
(A and B) 5  g/ml of cPTPRO–Fc was allowed to bind to E7 tissue 
sections (B). 10  g/ml of mIgG-1 was used as the negative control 
(A). Staining was most noticeable in the RGC layer, suggesting that 
this is the predominant location of binding partner(s) for cPTPRO. 
(C and D) Sections adjacent to those above were used to compare 
cPTPRO location. The optic fiber layer (OFL) and RGC layer were 
stained most strongly by anti-cPTPRO antibody (D). The IgG portion 
of preimmune serum was used as a control (C). Similar results were 
obtained in multiple experiments. INL, inner nuclear layer; IPL, inner 
plexiform layer; OPL, outer plexiform layer; PR, photoreceptors. The 
dark stained layer in all panels is pigment epithelium. Bar, 100  m. 
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onto the substrate before coating with cPTPRO. In two
experiments, neurite outgrowth (measured as percentage of
neurons with neurites) was inhibited 61% by PTPRO
added to the substrate after the LN coating, compared with
69% inhibition by PTPRO added simultaneously with the
LN. Taken together, these data indicate that the cPTPRO
ECD can inhibit retinal neurite growth induced by sub-
strate-bound LN.
Figure 4.  cPTPRO is antiadhesive for retinal neurons. Dissociated E6 retinal neurons were allowed to adhere for 2 h before fixation. (A) 
Neurons adhered equally well to the inner spot of LN/mIgG-1 and to the outer ring of LN alone (left). However, neurons did not adhere to an 
inner spot of LN/cPTPRO–Fc (right). (B) Quantitative data from adhesion assays in which cPTPRO–Fc or mIgG were mixed with LN and spot-
ted onto nitrocellulose-coated dishes. Data are expressed as a percentage of neurons adhering to a spot of LN alone (CON) and plotted as 
mean   SEM for three separate experiments. A dose-dependent decrease in adhesion was apparent with increasing concentrations of 
cPTPRO, from 12 to 100  g/ml. No such decrease was caused by mIgG-1. (C) Similar results were obtained from three experiments in which 
cPTPRO–Fc or mIgG-1 were mixed with N-cadherin. Data were plotted as the percentage of neurons adhering to a spot of N-cadherin alone 
(CON). Again a dose-dependent decrease in adhesion was observed with increasing concentrations of cPTPRO–Fc.
Figure 5.  cPTPRO inhibits LN-induced neurite out-
growth. Dissociated E6 chick retinal neurons were 
allowed to grow overnight, fixed, and photographed 
through a phase–contrast microscope. (A) PDL alone, 
(B) PDL plus10  g/ml LN, (C) PDL plus LN/50  g/ml 
cPTPRO–Fc, or (D) PDL plus LN/100  g/ml cPTPRO–
Fc. Neurons grew long neurites on PDL–LN. Neurites 
were noticeably fewer and shorter when cPTPRO was 
mixed with LN, especially at the higher concentration 
(D). Bar, 100  m. 
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The inhibitory effect of cPTPRO on retinal neurite growth
could also be demonstrated for growth induced by proteins
other than LN. Several other extracellular matrix proteins, in-
cluding collagen I and fibronectin, also promote neurite
growth from retinal neurons. We found that the cPTPRO
ECD was inhibitory to neurite growth induced by either of
these two proteins (Fig. 6, A–D). Further, the ability of
cPTPRO to inhibit neurite growth was not limited to extra-
cellular matrix inducers, as cPTPRO also strongly inhibited
neurite growth induced in retinal neurons by N-cadherin
(Fig. 6, E and F). Quantification of neurite growth data dem-
onstrated that cPTPRO inhibition of neurite growth was sta-
tistically significant when either the percentage of neurons
with neurites (Fig. 7, C–E) or the length of individual
neurites (unpublished data) was considered. The ability of
cPTPRO to inhibit neurite growth induced by this variety of
substrate proteins suggests that the effects are not due to
binding of cPTPRO to the inducing protein, or by binding
of cPTPRO to the neuronal receptors for these inducers.
Rather, the data suggest that cPTPRO delivers an inhibitory
signal to the cell by interacting with its own receptor.
 
cPTPRO induces retinal growth cone collapse
 
Proteins that inhibit neurite outgrowth by interacting with
specific inhibitory receptors are candidates for repulsive ax-
onal guidance cues. Such repulsive guidance cues may be as-
sayed in vitro using growth cone collapse assays. For exam-
ple, several of the best-known families of repulsive guidance
proteins, including semaphorins, ephrins, slits, and bone
morphogenetic proteins, exhibit growth cone collapsing ac-
tivity in vitro (Luo et al., 1993; Drescher et al., 1995).
Therefore, we tested the growth cone collapsing ability of
cPTPRO to determine whether cPTPRO might also act as a
repulsive guidance cue. In these assays, we added various
concentrations of soluble cPTPRO–Fc (or mIgG-1 as a con-
trol) to cultures of E6 retinal explants 30 min before fixa-
tion. We found that concentrations of cPTPRO as low as 60
pM had clear collapsing ability, and that this activity was al-
ready saturated at 0.6 nM (Fig. 8). The potency of the
cPTPRO ECD in collapsing growth cones, as well as the
percentage of growth cones collapsed at saturating cPTPRO
concentrations, were similar to the values seen previously for
ephrin A5–Fc, another repulsive guidance cue for retinal
neurons (Wahl et al., 2000), and for the collapse of dorsal
root ganglia growth cones by semaphorin IIIA (Luo et al.,
1993).
 
cPTPRO is a repulsive guidance cue for retinal axons
 
The ability of the cPTPRO ECD to inhibit neurite growth
when present on the substrate, combined with its growth
cone collapsing activity, suggests the possibility that
cPTPRO is a repulsive guidance cue for retinal neurons. To
test this possibility directly, we used a growth cone steering
assay designed to examine growth cone guidance in vitro.
This assay has been used to demonstrate growth cone steer-
ing by a variety of guidance proteins, including one type II
RPTP (Gundersen and Barrett, 1980; Zheng et al., 1994;
Ming et al., 1997; Song et al., 1997; Sun et al., 2000b). Be-
Figure 6.  cPTPRO inhibits neurite outgrowth on 
several growth-promoting substrates. Neurite growth 
was pronounced on 2- l spots of 100  g/ml rat tail 
collagen I (A), 20  g/ml fibronectin (C), and 20  g/ml 
N-cadherin–Fc (E). In contrast, when 100  g/ml 
cPTPRO–Fc was mixed with collagen, fibronectin, or 
N-cadherin–Fc, neurite outgrowth was noticeably 
reduced (B, D, and F, respectively). Bar, 100  m. 
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cause both cPTPRO and its putative binding partner are ex-
pressed by RGCs, we wished to examine the influence of
cPTPRO on the growth cones of RGC axons. Therefore, we
used retinal explants rather than dissociated neurons for
these experiments; the neurites leaving these explants are
mainly the axons of RGCs (Barnstable and Drager, 1984;
Akagawa and Barnstable, 1986; Sheppard et al., 1988;
McLoon and Barnes, 1989). RGC growth cones were sub-
jected to a stable gradient of soluble cPTPRO–Fc using the
methods described previously for the type II RPTP, PTP-
 
 
 
(Sun et al., 2000b). Within 15 min of the cPTPRO gradient
being established, growth cones turned away from the source
of the cPTPRO gradient (Fig. 9). Measurement of individ-
ual growth cone trajectories revealed that this repulsive turn-
ing response was quite consistent (Fig. 10 A), and quantifi-
cation demonstrated an average turning angle of 
 
 
 
 
 
20
 
 
 
(
 
n 
 
 
 
 22; Fig. 10 B), similar to earlier data using semaphorin
IIIA (Song et al., 1998). Control experiments with gradients
of mIgG showed no turning effect, demonstrating that the
repulsive effect of cPTPRO–Fc was due to the cPTPRO
ECD (Fig. 10, A and B).
RGC neurites tend to extend in a clockwise direction
on an LN substrate (Halfter et al., 1987), and this ten-
dency could be confirmed in our experiments (unpub-
lished data). To ensure that a clockwise bias could not ex-
plain the repulsive turning effects of cPTPRO–Fc, we
performed assays in which the pipette tip was oriented ei-
ther to the right (clockwise) or to the left (counterclock-
wise) of the migrating growth cone. In either case, a clear
and significant repulsive tendency was observed (
 
n 
 
 
 
 10
for each direction; unpublished data). Therefore, the
cPTPRO ECD is a repulsive growth cone steering protein
for RGC axons.
 
Poo and collaborators have shown that most growth cone
steering molecules can be classified into two groups, depend-
ing on the sensitivity of the steering response to removal of
extracellular Ca
 
2
 
 
 
 and to changes in cyclic nucleotide levels
(Ming et al., 1997; Song et al., 1997, 1998). For group I
proteins (e.g., netrin, brain-derived neurotrophic factor
[BDNF], myelin-associated glycoprotein [MAG]), attractive
steering responses can be converted to repulsion by reducing
intracellular cAMP activity, and repulsion can be converted
to attraction by increasing cAMP. In group II (semaphorin
III, NT-3) attractive responses can be converted to repulsion
by reducing intracellular cGMP, and repulsion can be con-
verted to attraction by increasing cGMP levels. We recently
identified the ECD of a type II RPTP, PTP-
 
 
 
, as an attrac-
tive growth cone steering protein; it belongs neither to group
I nor to group II (Sun et al., 2000b). To determine whether
the cPTPRO ECD belongs to group I or II, we increased cy-
clic nucleotide levels in retinal neurons before exposing them
to gradients of cPTPRO–Fc. Application of Sp-cAMPs (to
increase cAMP) had no effect on the repulsive activity of
cPTPRO–Fc (
 
n 
 
  
 
12; Fig. 10, A and B). However, applica-
tion of 8-Br-cGMP (to increase cGMP) converted cPTPRO-
mediated repulsion into attraction (
 
n 
 
 
 
 13; Fig 10, A and
B). Thus, the cPTPRO ECD can be classified as a repulsive
group II guidance protein in vitro.
 
Discussion
 
Our major finding is that the ECD of cPTPRO, a type III
RPTP, is an antiadhesive and neurite inhibitory ligand for
retinal neurons in vitro. Further, direct tests demonstrate
that the cPTPRO ECD is a potent growth cone collapsing
signal, and acts as a type II repulsive guidance cue for RGC
Figure 7.  cPTPRO inhibition of 
outgrowth induced by different 
substrates. The percentage of neurons 
with neurites (A, C–E) or the mean 
length of neurites (B) was plotted for 
control substrates (LN; Col, Collagen I; 
FN, fibronectin; and N-cad, N-cad-
herin) and for substrates mixed with 
the indicated concentrations of
cPTPRO–Fc (in  g/ml). (A and B)
cPTPRO–Fc inhibited neurite growth 
on LN in a dose-dependent manner. 
(A) The percentage of neurons with 
neurites was significantly reduced by 
cPTPRO at each concentration tested, 
but not by mIgG. (B) The length of reti-
nal neurites was significantly reduced 
by cPTPRO. Inhibition of neurite out-
growth by cPTPRO–Fc was also 
apparent on a substrate of 100  g/ml 
collagen (B), 20  g/ml fibronectin (C), 
and 20  g/ml N-cadherin (D). A slight 
(19%) inhibitory effect was seen
with high concentrations of IgG on 
fibronectin for unknown reasons. All 
plots show the mean results for four 
independent experiments   SEM as 
a percentage of the control condition 
except D, which is the mean of three experiments. *P   0.05, ***P   0.001, significantly different from control. Statistics were done
on InStat
® using three-way analysis of variance and Bonferroni’s posttest to compare each column to control. 
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growth cones. Our findings comprise the first evidence for a
functional effect of a type III RPTP on vertebrate neurons,
and suggest that this class of RPTP operates in a manner dis-
tinct from the more widely studied type II RPTPs. Together
with our data on the expression of cPTPRO, these results
suggest that PTPRO has a functional role in vertebrate neu-
ral development.
A variety of independent assays confirm the inhibitory
and/or repulsive effects of cPTPRO. The PTPRO ECD is
antiadhesive and inhibits neurite growth when presented as
a substrate protein. Similarly, soluble PTPRO collapses
growth cones and is a specific repulsive steering signal when
presented in a gradient. Furthermore, PTPR
 
O
 
 inhibits
growth induced by numerous distinct growth-promoting
proteins, which in turn act through a diverse array of neu-
ronal receptors. Therefore, it is unlikely that PTPRO exerts
its inhibitory effect by direct interference with the binding
functions of positively acting receptors. Rather, our results
 
suggest that PTPR
 
O
 
 acts through one or more specific re-
ceptors on the neuronal surface that send an inhibitory sig-
nal to the growth cone machinery.
PTPRO mRNA is selectively expressed in the brain and
kidney, and is expressed most strongly during embryonic de-
velopment (Thomas et al., 1994; Bodden and Bixby, 1996;
Tagawa et al., 1997; Chilton and Stoker, 2000). Our pro-
tein expression data are in agreement with these observations
and indicate that cPTPRO is mainly expressed in the fore-
brain from E7 to E14, the major period of axonogenesis in
the chick (Rogers, 1957; De Long and Coulombre, 1965).
Similarly, cPTPR
 
O
 
 in the retinotectal system is highly ex-
pressed during development, and concentrated on the axons
of projection neurons, both in the retina and in the tectum
(Ledig et al., 1999b). PTPRO is also likely to be important
in development in other areas of the nervous system. Recent
expression studies have found PTPR
 
O
 
 mRNA in several
types of brain projection neurons and most peripheral gan-
glia during mouse development (unpublished data).
The ectodomains of numerous type II RPTPs, as well as
the type V RPTP PTP-
 
 
 
, have been shown to be adhe-
sive, neurite growth–promoting molecules in vitro (Maeda
and Noda, 1996; Burden-Gulley and Brady-Kalnay, 1999;
Drosopoulos et al., 1999; Garwood et al., 1999; Ledig et al.,
1999a; Revest et al., 1999; Wang and Bixby, 1999). In some
circumstances the PTP-
 
 
 
 ECD, which is a chondroitin sul-
fate proteoglycan, can also act as a neurite inhibitory ligand
(Maeda and Noda, 1996). Our results demonstrate that the
ECD from a type III RPTP can provide a neurite inhibitory
and growth cone repellant signal to neurons. The only other
RPTP that has been shown to steer growth cones is PTP-
 
 
 
,
which is a growth cone attractant whose activity is not influ-
enced by changes in cyclic nucleotide levels. The intracellu-
lar signaling pathway triggered by PTPR
 
O
 
 remains a mys-
tery. Growth cone steering experiments indicate that cGMP
plays a modulatory role, but there is no evidence that this is
a primary element of the signaling pathway. In the case of
group I (cAMP-regulated) guidance cues, it appears that dis-
tinct cues operate through shared signaling pathways, in-
cluding the phosphatidylinositol 3-kinase and PLC-
 
 
 
 path-
ways (Song and Poo, 1999). If this is also true for group II
(cGMP-regulated) guidance cues, observations on the other
group II proteins, semaphorin 3A and NT-3, might be rele-
vant. The signaling pathway of semaphorin 3A, which is the
only other group II chemorepellant, appears to involve both
Rac1 and collapsin response mediator proteins (Nakamura
et al., 2000). NT-3 signaling has been linked to the Ras–
mitogen-activated preotein kinase pathway and the PLC-
 
 
pathway in hippocampal pyramidal neurons (Marsh and
Palfrey, 1996).
There are no known ligands for cPTPRO or any type III
RPTP. Several type II RPTPs bind homophilically, includ-
ing PTP- , PTP- , PTP- , and HmLAR2 (Brady-Kalnay et
al., 1993; Gebbink et al., 1993; Sap et al., 1994; Wang and
Bixby, 1999; Baker et al., 2000). Other type II RPTPs are
presumed to have heterophilic ligands and/or receptors, in-
cluding CRYP- /PTP-  (Haj et al., 1999; Ledig et al.,
1999a). Our data for PTPRO also suggest a heterophilic
ligand(s). First, cPTPRO and its presumptive binding part-
ner exhibit differential staining patterns in the developing
Figure 8.  cPTPRO–Fc induces collapse of retinal growth cones. E6 
chick retinal neurons were plated on glass coverslips coated with 
PDL and 10  g/ml LN. After 10 h of culture, cPTPRO–Fc or mIgG-1 
was added to the wells in 100  l of medium. The same volume of 
medium was added to control wells. After 30 min, the cells were 
fixed and growth cones were scored as open or collapsed. (A) Control 
neurites had well-spread growth cones, in contrast to neurites treated 
with 6 nM cPTPRO–Fc (B). (C) Quantification of the growth cone col-
lapsing effect. The percentage of collapsed growth cones (mean   
SEM) was plotted for control neurons and neurons treated with vari-
ous concentrations of cPTPRO–Fc or mIgG. Concentrations are given 
in nM. Neurons treated with cPTPRO–Fc showed significantly higher 
levels of growth cone collapse than controls. Bar, 10  m. cPTPRO is a repulsive guidance cue | Stepanek et al. 875
It is interesting that the ECDs of PTP-  and PTPRO
were found to have such different effects on neuronal adhe-
sion and axon growth. The PTP-  ECD mediates neuronal
adhesion, stimulates neurite growth, and is an attractive
guidance cue in vitro (Wang and Bixby, 1999; Sun et al.,
2000a). The PTPRO ECD is antiadhesive, inhibits neurite
growth, and is a group II repulsive guidance cue in vitro.
PTP-  and other type II RPTPs have the extracellular struc-
tures of Ig superfamily CAMs, thus their positive effects on
axon growth might be predicted. On the other hand, Eph
receptors have ECDs consisting of one Ig domain and two
fibronectin type III repeats (Pandey et al., 1995), and many
Eph receptor–ephrin interactions are neurite inhibitory
(Drescher et al., 1997; Mellitzer et al., 2000). No such pre-
cedents exist for type III RPTPs, as ECDs comprising only
multiple fibronectin type III repeats are not known for other
protein families. However, the functional differences seen in
our studies may relate to a genetic antagonism seen among
RPTPs in Drosophila. The motor axons in the intersegmen-
tal nerve terminate without reaching normal branch points
in embryos lacking three RPTPs, including two type IIa
RPTPs (Dlar and PTP69D). If PTP10D (a cPTPRO homo-
logue) is removed from flies in this background, the pheno-
type is partially rescued, suggesting that PTP10D acts in op-
position to the other RPTPs in this context (Sun et al.,
2001). Our finding that cPTPRO, unlike vertebrate type II
RPTPs, acts as a neurite inhibitory ligand, suggests a poten-
tial functional explanation for this genetic antagonism.
Materials and methods
Materials
Fertilized White Leghorn eggs were purchased from Spafas and incubated
at 38 C in a humidified chamber until use. Cell culture media were pur-
chased from University of Miami Sylvester Comprehensive Cancer Center
Cell Culture and Media Supplies Facility. CHO-K1 cells were a gift from
Dr. Kerry Burnstein (University of Miami, Miami, FL). An N-cadherin–Fc
fusion protein was produced and purified by cloning the entire ECD of
chick N-cadherin into the Fc fusion vector already described, and using
the purification methods described (Wang and Bixby, 1999). Recombinant
N-cadherin–Fc had neurite growth–promoting ability similar to that seen
with purified native N-cadherin (unpublished data). All other reagents
were purchased from Sigma-Aldrich unless specified.
Figure 9.  A growth cone from an 
embryonic chick RGC turns away from 
a source of cPTPRO–Fc during the 
application of a cPTPRO–Fc gradient. 
The growth cone was migrating in a 
vertical direction before gradient onset, 
but turned away from the pipette (upper 
right corner) within 15 min of gradient 
onset, and continued to move away 
from the source over the next 15 min. 
Times are given relative to onset of the 
gradient.
retina. Second, the cPTPRO ECD is not adhesive for neu-
rons expressing cPTPRO. The nature of ligand–receptor in-
teractions for cPTPRO is still unclear. PTPRO binding
partners may act as receptors for the PTPRO ECD, as
ligands for the PTPRO receptor, or both. Because there is
overlap in the expression patterns of cPTPRO and its puta-
tive ligand, we must also consider the possibility that these
interactions occur in a “cis” fashion within the plane of the
plasma membrane. A transmembrane protein known as
gp150 has been characterized as a substrate and potential cis
binding partner for PTP10D, which is the closest Drosophila
homologue of PTPRO (Fashena and Zinn, 1997). The
functional significance of gp150–PTP10D interactions is
not yet known.
Genetic knockout experiments in Drosophila suggest that
RPTPs play key roles in axon growth and guidance, but also
suggest complex interactions among these proteins as well as
some functional redundancy. For instance, flies with a muta-
tion in PTP10D have no obvious nervous system abnormal-
ities. Similarly, flies lacking PTP69D have no clear central
nervous system phenotype. However, mutants that lack
both PTP10D and PTP69D exhibit abnormal midline
crossing by a subset of longitudinal axons. When all four
nervous system–specific RPTPs are knocked out, this phe-
notype is greatly exacerbated (Sun et al., 2000a). In contrast,
whereas removing the type II RPTP Dlar causes some motor
axons to bypass their target, removal of a second RPTP,
DPTP99A, tends to rescue the phenotype. A similar com-
plexity is likely to exist in the vertebrate. Genetic deletions
of RPTPs in mice have yielded animals with central nervous
system abnormalities (Yeo et al., 1997; Elchebly et al., 1999;
Wallace et al., 1999; Harroch et al., 2000; Uetani et al.,
2000), but the roles of these proteins in axon growth will
likely be clear only through more intensive analysis and ex-
amination of double and triple knockouts. The function of
PTPRO in axon growth in vivo is not yet known. Other
proteins shown to act as repellant growth cone steering pro-
teins in vitro have generally been found to guide axons in
vivo. A detailed examination of the nervous system in the
PTPRO knockout mouse (Wharram et al., 2000) should
provide clear information on this issue.876 The Journal of Cell Biology | Volume 154, 2001
Expression and purification of cPTPRO–Fc
A unique SpeI site was introduced at the 3  end of a cDNA fragment en-
coding the entire ECD of cPTPRO (Bodden and Bixby, 1996) by PCR. This
product was cloned in frame, upstream of the Fc region of mouse IgG-1,
and subcloned into the pcDNA3 expression vector as described (Wang
and Bixby, 1999). CHO-K1 cells were stably transfected with purified
cPTPRO–Fc as described (Wang and Bixby, 1999). Established cell lines
were screened for expression by Western blot analysis of conditioned me-
dia with anti-cPTPRO antibody. Purification was performed as described,
except that 0.5  M of the protease inhibitor PMSF was added into the con-
ditioned medium before passing it through the anti–mIgG-1 column. West-
ern blotting for cPTPRO and the fusion protein was performed essentially
as described previously (Bixby and Jhabvala, 1990). The primary antibody
comprised 0.5  g/ml of anti–CRYP-2 IgG, immunopurified from an antise-
rum raised against a CRYP-2–GST fusion protein that has previously been
characterized (Ledig et al., 1999b).
Immunohistochemistry
Frozen 10- m sections of E7 chick retina were prepared as described
(Ledig et al., 1999b). For binding experiments, 5  g/ml cPTPRO–Fc or 10
 g/ml mIgG-1 was allowed to bind to the sections overnight. The sections
were rinsed and 1:250 dilution of goat anti–mouse IgG was added, fol-
lowed by 1:250 dilution of anti–goat-HRP. Sections stained for cPTPRO
were treated with the rabbit anti–CRYP-2 antibody followed by anti–rab-
bit-HRP. HRP immunohistochemistry was performed with diaminobenzi-
dine–nickel substrate.
Adhesion assays
Cultures of dissociated neurons from E6 retina were prepared as described
(Perron and Bixby, 1999). Retinal cultures are  70% neuronal by the crite-
rion of neurite outgrowth and neurofilament expression. Neuronal adhe-
sion assays were performed as described (Wang and Bixby, 1999). For se-
quential spotting experiments, 1  l of cPTPRO (50  g/ml) or mIgG was
spotted onto the dish. After incubation for 15 min, the remaining protein
was removed by pipette and 10  l of LN (10  g/ml) was spotted so as to
cover and surround the first spot. Neurons were plated at 5   10
5 cells/35-
mm dish and allowed to adhere for 2 or 24 h before fixation. For simulta-
neous spotting experiments, 20  g/ml LN or 10  g/ml N-cadherin–Fc was
mixed on ice with cPTPRO–Fc or control mIgG immediately before spot-
ting on the dish.
Neurite outgrowth assays
Assays were performed as described previously (Bixby and Jhabvala,
1990). Proteins were spotted on an LN- or PDL-coated dish, except for
N-cadherin experiments which used a nitrocellulose substrate. After 1 h,
dishes were rinsed and blocked with culture medium. Neurons were al-
lowed to grow 14–16 h before fixation. Using NIH Image software, video
images of the cultures were used to measure average neurite lengths only
in cells in which neurites were longer than twice the cell body diameter.
At least 100 neurites were measured per spot of protein. For the percent-
age of neurons with neurites, all cells within the protein spot (at least 500
cells/spot) were counted.
Growth cone collapse assay
Collapse assays followed the protocol of Goshima et al. (1995). Retinal ex-
plants were plated on LN-coated glass coverslips in 24-well plates in 250
 l of culture medium. After 10 h, cPTPRO–Fc or mouse IgG-1 as a control
was added in a small amount of retinal culture medium, and the cells were
incubated at 37 C for 30 min before fixation. Growth cones were scored as
collapsed or not collapsed, and those with an intermediate morphology
were not counted.
Growth cone steering assay
The growth cone steering assay was performed on neurites emanating
from explants of E6 retina essentially as described for forebrain neurons
(Sun et al., 2000b). Explants were plated on a collagen substrate 1 d be-
fore the experiment. CPTPRO–Fc was added to the micropipette at a
concentration of 10  g/ml. The initial concentration experienced by
the growth cone at the onset of the gradient was calculated to be  400
ng/ml (1 nM; Sun et al., 2000b). The final turning angle was defined as
the angle between the original direction of neurite extension and a
straight line connecting the position of the growth cone at the begin-
ning and end of the experiment. For experiments with cyclic nucle-
otides, 20  M Sp-cAMP or 100  M Br-cGMP was added at least 30 min
before the recording period.
Digital images
Digital images were prepared with Adobe Photoshop
® (v5.02).
Statistics
Statistics were done using InStat
® (v2.03).
Figure 10.  Summary of growth cone turning in response to
cPTPRO. (A) Superimposed traces of growth cone trajectories in 
response to gradients of either cPTPRO–Fc or mIgG-1. The origin 
represents the position of the growth cone at the gradient onset, and 
the vertical line represents the original direction of growth (before 
gradient onset). Large arrows represent the position of the pipette at 
 45  to the original direction of growth. Almost all growth cones 
tested turned away from the source of cPTPRO–Fc. In contrast, 
growth cones maintained their original heading in the presence of 
an IgG gradient. Addition of Sp-cAMPs had no effect on the repul-
sive effect of cPTPRO, but the addition of 8-Br-cGMP converted 
cPTPRO-mediated repulsion into attraction. (B) Quantification of 
the mean final turning angle (  SEM) of the growth cones after a 1-h 
gradient application. The repulsive effects of cPTPRO–Fc, and the 
attraction in the presence of 8-Br-cGMP, are clearly shown. 
*P   0.05, significantly different from IgG control; **P   0.01, 
significantly different from control. Numbers in parentheses indicate 
the number of growth cones examined. cPTPRO is a repulsive guidance cue | Stepanek et al. 877
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